Position in MRK
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$213,940,806
+$9,402,218 QoQ
Shares Held
1,664,909
-2.1% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#128
of 3,768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. MRK ranks #3 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,876,785 | $723,914,175 | |
| 2 | LLY |
ELI LILLY & Co
|
425,688 | $510,582,998 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
1,664,909 | $213,940,806 | |
| 4 | JNJ |
Johnson & Johnson
|
688,542 | $174,869,011 | |
| 5 | NVO |
Novo Nordisk A S
|
2,924,500 | $140,200,529 | |
| 6 | AMGN |
Amgen Inc
|
54,394 | $19,697,155 | |
| 7 | PFE |
Pfizer Inc
|
233,339 | $5,618,802 | |
| 8 | NVS |
Novartis AG
|
28,162 | $4,413,548 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,940,806 | 1,664,909 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $204,538,588 | 1,700,379 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $183,140,714 | 1,739,889 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $201,962,603 | 2,406,322 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $207,456,590 | 2,620,725 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $261,865,015 | 2,917,391 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $318,824,147 | 3,204,907 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $328,777,888 | 2,895,191 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $361,736,171 | 2,921,940 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $290,764,491 | 2,203,596 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $263,070,819 | 2,413,051 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $253,592,307 | 2,463,257 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $276,429,552 | 2,395,611 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $351,127,000 | 3,300,376 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $380,717,601 | 3,431,434 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $298,221,242 | 3,462,857 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $315,770,575 | 3,463,536 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $283,887,582 | 3,459,934 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $265,061,354 | 3,458,525 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $256,126,675 | 3,410,021 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $265,444,407 | 3,413,198 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $263,918,680 | 3,423,512 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $271,692,277 | 3,321,423 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $270,776,047 | 3,264,327 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $250,594,700 | 3,240,587 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $248,955,728 | 3,235,714 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||